Active‐Controlled Trial Design for HIV Prevention Trials With a Counterfactual Placebo
|
In the quest for enhanced HIV prevention methods,
the advent of antiretroviral drugs as pre-exposure prophylaxis (PrEP) has
marked a significant ... |
Gilead's lenacapavir applications for HIV gain EMA validation
Gilead's lenacapavir gained approval in several nations for treating the adult population with multi-drug resistant HIV in conjunction with other ... View article...